Anthropic, PBC (ANT) Stock Analysis

Verdict: AVOID

An extremely high P/S ratio of 36x with a $41.9 billion loss makes Anthropic a highly speculative investment after its IPO.

Investment score: 30/100

Analysis as of

Is Anthropic, PBC stock worth reviewing? The TradeMates thesis

The TradeMates model rates Anthropic as AVOID after its IPO. Despite strong revenue growth to USD 4.59 billion in 2025, this is offset by a net loss of USD 41.97 billion and a P/S valuation of 36.04x.

7-factor investment score

Anthropic, PBC opportunities and risks

What speaks for ANT

What speaks against ANT

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
ANT0.0x36.0xn/a38.3%-342.7%0.0%
MSFT26.0x10.7x17.1x67.7%41.2%1.6%
ORCL17.0x4.7x12.0x64.0%26.4%-8.6%
PANW574.2x23.8x278.4x68.9%3.7%1.5%
CRWD6916.5x46.2x561.0x75.2%1.1%0.6%
FTNT42.4x12.3x31.6x79.7%29.0%3.6%
Peer median42.4x12.3x31.6x68.9%26.4%1.5%

Frequently asked questions about Anthropic, PBC (ANT)

Is ANT stock a good investment?

The TradeMates model rates Anthropic, PBC as AVOID with an investment score of 30/100. The TradeMates model rates Anthropic as AVOID after its IPO. Despite strong revenue growth to USD 4.59 billion in 2025, this is offset by a net loss of USD 41.97 billion and a P/S valuation of 36.04x. This is algorithmic model output, not personal investment advice.

Is ANT stock a buy?

The TradeMates model verdict for ANT is AVOID with an investment score of 30/100. Treat this as a model signal to review, not a personal buy recommendation.